Dr. Eleanor Fish, Advisory Board Member, Awarded Order of Canada
January 06, 2022 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife’s Wholly-Owned Subsidiary, Altum Pharmaceuticals, Obtains Non-Dilutive Financing Commitment From Strategic Investor!
December 22, 2021 10:30 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 22, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly-owned...
BetterLife Successfully Completes Phase 1 and Initiates Phase 2 Clinical Trials with Interferon Alpha-2b in COVID-19 Patients in Chile
November 29, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly owned...
Early Results of BetterLife Preclinical Study Show AP-003 (rhIFN⍺2b) Provides Up to 97% Protection in Human Cells Against the Delta Variant of SARS-CoV-2
October 12, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Oct. 12, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:NPAU ), an emerging biotech company focused on...
BetterLife Enrolls First Patient in Interferon alpha-2b COVID-19 Trial in Chile
September 22, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly owned...
BetterLife to Present at the Emerging Growth Conference on September 15, 2021
September 13, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotechnology company...
BetterLife Initiates Preclinical Study of AP-003 (rhIFNa2b) against Delta Variant of SARS-CoV-2
August 25, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotechnology company...
BetterLife Receives Approval to Conduct COVID-19 Randomized Placebo-Controlled Trial with Pontificia Universidad Católica de Chile
July 27, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly owned...
Sunrise Diagnostic Laboratory Brings Advanced COVID-19 Diagnostic Testing in NJ
July 27, 2021 00:29 ET
|
Sunrise Group of Companies
South Plainfield, New Jersey, July 27, 2021 (GLOBE NEWSWIRE) -- Founder and Chairman Sunrise Group of Companies: Mr. Mohammed Naeem Owing to the ongoing pandemic situation, Sunrise Diagnostic...
Early Results of BetterLife Preclinical Study Showing AP-003 (rhIFNa2b) has Similar Potent Efficacy Against Different Variants of COVID-19
July 15, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 15, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotechnology company...